PD 06 - Confronting AMR beyond the COVID-19 Pandemic

COVID-19 currently overshadows the silent pandemic of antimicrobial resistance, but we can be sure antimicrobial resistance will resurface once the dust will settle and it likely will be more challenging than ever. Inappropriately treated or untreated bacterial infections are a major cause of mortality and morbidity, especially in low- and middle-income countries (LMICs), where an estimated 5.7 million antibiotic-treatable deaths occur annually. This session will focus on how we can ensure the necessary political leadership to address the silent pandemic of antimicrobial resistance. Considering the discussions at the G7 and the formation of the Triparite Global Leaders Group on AMR, the panel will focus on what needs to be done on a political level to ensure an appropriate response to the threat of AMR.